Tax-exempt hospitals in the 340B drug savings program provided $56.1 billion in total benefits to their communities in 2016, the most recent year for which data is available, according to an analysis released today by the AHA. “Hospitals and health systems of all kinds and sizes are hard at work delivering a wide variety of benefits tailored to meet the needs of their diverse communities,” said AHA Executive Vice President Tom Nickels. “This report demonstrates once again the significant value that the 340B drug savings program allows eligible hospitals to provide for their communities through a range of important programs and services, many of which would otherwise be unavailable.” Funded by drug company discounts, not federal dollars, the 340B program was created by Congress more than 25 years ago “to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services.”

Related News Articles

Headline
The AHA Jan. 26 urged the Health Resources and Services Administration to take immediate action to stop a new Eli Lilly and Company policy from taking effect…
Headline
(Updated Jan. 23) A measles outbreak in South Carolina has reached 700 cases, the state’s Department of Public Health reported. The outbreak, initially…
Headline
The federal government has dropped its appeal of a preliminary injunction blocking implementation of the Department of Health and Human Services’ 340B Rebate…
Headline
Jesse Tamplen, vice president of care coordination at John Muir Health in San Francisco, and Jamie Elmasu, director of community health improvement at John…
Headline
A study released Jan. 12 by the Journal of the American College of Cardiology analyzed the current state of heart health in the U.S., highlighting the…
Headline
The 1st U.S. Circuit Court of Appeals Jan. 7 denied the government’s motion for a stay in a lawsuit filed by the AHA, the Maine Hospital Association and four…